[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Meningococcal Infections Vaccine Sales Market Report 2018

June 2018 | 108 pages | ID: GAF7660E412EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Meningococcal Infections Vaccine market status and forecast, categorizes the global Meningococcal Infections Vaccine market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Meningococcal Infections Vaccine market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report
  • Sanofi-Pasteur
  • Beijing Tiantan Biological Products
  • Shanghai Institute of Biological Products
  • Wuhan Institute of Biological Products
  • Lanzhou Institute of Biological Products
  • Hualan Biological Engineering
  • Chongqing Zhifei Biological Products
  • Zhejiang Tianyuan Bio-Pharmaceutical
  • Walvax Biotechnology
  • Royal(Wuxi) Bio-Pharmaceutical
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
We can also provide the customized separate regional or country-level reports, for the following regions:
  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Meningococcal Conjugate Vaccines
  • Meningococcal Polysaccharide Vaccine
  • Serogroup B Meningococcal Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Children
  • Preteens/Teens
  • Adults
The study objectives of this report are:
  • To analyze and study the global Meningococcal Infections Vaccine sales, value, status (2013-2017) and forecast (2018-2025);
  • To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
  • Focuses on the key Meningococcal Infections Vaccine players, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Meningococcal Infections Vaccine are as follows:
  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Meningococcal Infections Vaccine Manufacturers
Meningococcal Infections Vaccine Distributors/Traders/Wholesalers
Meningococcal Infections Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
  • Regional and country-level analysis of the Meningococcal Infections Vaccine market, by end-use.
  • Detailed analysis and profiles of additional market players.
Global Meningococcal Infections Vaccine Sales Market Report 2018

1 MENINGOCOCCAL INFECTIONS VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Meningococcal Infections Vaccine
1.2 Classification of Meningococcal Infections Vaccine by Product Category
  1.2.1 Global Meningococcal Infections Vaccine Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Meningococcal Infections Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Meningococcal Conjugate Vaccines
  1.2.4 Meningococcal Polysaccharide Vaccine
  1.2.5 Serogroup B Meningococcal Vaccine
1.3 Global Meningococcal Infections Vaccine Market by Application/End Users
  1.3.1 Global Meningococcal Infections Vaccine Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Children
  1.3.2 Preteens/Teens
  1.3.3 Adults
1.4 Global Meningococcal Infections Vaccine Market by Region
  1.4.1 Global Meningococcal Infections Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Meningococcal Infections Vaccine Status and Prospect (2013-2025)
  1.4.3 Europe Meningococcal Infections Vaccine Status and Prospect (2013-2025)
  1.4.4 China Meningococcal Infections Vaccine Status and Prospect (2013-2025)
  1.4.5 Japan Meningococcal Infections Vaccine Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Meningococcal Infections Vaccine Status and Prospect (2013-2025)
  1.4.7 India Meningococcal Infections Vaccine Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Meningococcal Infections Vaccine (2013-2025)
  1.5.1 Global Meningococcal Infections Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 Global Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2025)

2 GLOBAL MENINGOCOCCAL INFECTIONS VACCINE COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Meningococcal Infections Vaccine Market Competition by Players/Suppliers
  2.1.1 Global Meningococcal Infections Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Meningococcal Infections Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Meningococcal Infections Vaccine (Volume and Value) by Type
  2.2.1 Global Meningococcal Infections Vaccine Sales and Market Share by Type (2013-2018)
  2.2.2 Global Meningococcal Infections Vaccine Revenue and Market Share by Type (2013-2018)
2.3 Global Meningococcal Infections Vaccine (Volume and Value) by Region
  2.3.1 Global Meningococcal Infections Vaccine Sales and Market Share by Region (2013-2018)
  2.3.2 Global Meningococcal Infections Vaccine Revenue and Market Share by Region (2013-2018)
2.4 Global Meningococcal Infections Vaccine (Volume) by Application

3 UNITED STATES MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Meningococcal Infections Vaccine Sales and Value (2013-2018)
  3.1.1 United States Meningococcal Infections Vaccine Sales and Growth Rate (2013-2018)
  3.1.2 United States Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2018)
  3.1.3 United States Meningococcal Infections Vaccine Sales Price Trend (2013-2018)
3.2 United States Meningococcal Infections Vaccine Sales Volume and Market Share by Players (2013-2018)
3.3 United States Meningococcal Infections Vaccine Sales Volume and Market Share by Type (2013-2018)
3.4 United States Meningococcal Infections Vaccine Sales Volume and Market Share by Application (2013-2018)

4 EUROPE MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Meningococcal Infections Vaccine Sales and Value (2013-2018)
  4.1.1 Europe Meningococcal Infections Vaccine Sales and Growth Rate (2013-2018)
  4.1.2 Europe Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Meningococcal Infections Vaccine Sales Price Trend (2013-2018)
4.2 Europe Meningococcal Infections Vaccine Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Meningococcal Infections Vaccine Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Meningococcal Infections Vaccine Sales Volume and Market Share by Application (2013-2018)

5 CHINA MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 China Meningococcal Infections Vaccine Sales and Value (2013-2018)
  5.1.1 China Meningococcal Infections Vaccine Sales and Growth Rate (2013-2018)
  5.1.2 China Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2018)
  5.1.3 China Meningococcal Infections Vaccine Sales Price Trend (2013-2018)
5.2 China Meningococcal Infections Vaccine Sales Volume and Market Share by Players (2013-2018)
5.3 China Meningococcal Infections Vaccine Sales Volume and Market Share by Type (2013-2018)
5.4 China Meningococcal Infections Vaccine Sales Volume and Market Share by Application (2013-2018)

6 JAPAN MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Meningococcal Infections Vaccine Sales and Value (2013-2018)
  6.1.1 Japan Meningococcal Infections Vaccine Sales and Growth Rate (2013-2018)
  6.1.2 Japan Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Meningococcal Infections Vaccine Sales Price Trend (2013-2018)
6.2 Japan Meningococcal Infections Vaccine Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Meningococcal Infections Vaccine Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Meningococcal Infections Vaccine Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Meningococcal Infections Vaccine Sales and Value (2013-2018)
  7.1.1 Southeast Asia Meningococcal Infections Vaccine Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Meningococcal Infections Vaccine Sales Price Trend (2013-2018)
7.2 Southeast Asia Meningococcal Infections Vaccine Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Meningococcal Infections Vaccine Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Meningococcal Infections Vaccine Sales Volume and Market Share by Application (2013-2018)

8 INDIA MENINGOCOCCAL INFECTIONS VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 India Meningococcal Infections Vaccine Sales and Value (2013-2018)
  8.1.1 India Meningococcal Infections Vaccine Sales and Growth Rate (2013-2018)
  8.1.2 India Meningococcal Infections Vaccine Revenue and Growth Rate (2013-2018)
  8.1.3 India Meningococcal Infections Vaccine Sales Price Trend (2013-2018)
8.2 India Meningococcal Infections Vaccine Sales Volume and Market Share by Players (2013-2018)
8.3 India Meningococcal Infections Vaccine Sales Volume and Market Share by Type (2013-2018)
8.4 India Meningococcal Infections Vaccine Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL MENINGOCOCCAL INFECTIONS VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Sanofi-Pasteur
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Beijing Tiantan Biological Products
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Shanghai Institute of Biological Products
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Wuhan Institute of Biological Products
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Lanzhou Institute of Biological Products
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Hualan Biological Engineering
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Hualan Biological Engineering Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Chongqing Zhifei Biological Products
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Zhejiang Tianyuan Bio-Pharmaceutical
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Walvax Biotechnology
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Walvax Biotechnology Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Royal(Wuxi) Bio-Pharmaceutical
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Meningococcal Infections Vaccine Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview

10 MENINGOCOCCAL INFECTIONS VACCINE MAUFACTURING COST ANALYSIS

10.1 Meningococcal Infections Vaccine Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Meningococcal Infections Vaccine
10.3 Manufacturing Process Analysis of Meningococcal Infections Vaccine

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Meningococcal Infections Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Meningococcal Infections Vaccine Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL MENINGOCOCCAL INFECTIONS VACCINE MARKET FORECAST (2018-2025)

14.1 Global Meningococcal Infections Vaccine Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Meningococcal Infections Vaccine Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Meningococcal Infections Vaccine Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Meningococcal Infections Vaccine Price and Trend Forecast (2018-2025)
14.2 Global Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Meningococcal Infections Vaccine Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Meningococcal Infections Vaccine Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Meningococcal Infections Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Meningococcal Infections Vaccine Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Meningococcal Infections Vaccine Sales Forecast by Type (2018-2025)
  14.3.2 Global Meningococcal Infections Vaccine Revenue Forecast by Type (2018-2025)
  14.3.3 Global Meningococcal Infections Vaccine Price Forecast by Type (2018-2025)
14.4 Global Meningococcal Infections Vaccine Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Meningococcal Infections Vaccine
Figure Global Meningococcal Infections Vaccine Sales Volume Comparison (K doses) by Type (2013-2025)
Figure Global Meningococcal Infections Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Meningococcal Conjugate Vaccines Product Picture
Figure Meningococcal Polysaccharide Vaccine Product Picture
Figure Serogroup B Meningococcal Vaccine Product Picture
Figure Global Meningococcal Infections Vaccine Sales Comparison (K doses) by Application (2013-2025)
Figure Global Sales Market Share of Meningococcal Infections Vaccine by Application in 2017
Figure Children Examples
Table Key Downstream Customer in Children
Figure Preteens/Teens Examples
Table Key Downstream Customer in Preteens/Teens
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Global Meningococcal Infections Vaccine Market Size (Million USD) by Regions (2013-2025)
Figure United States Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate (2013-2025)
Figure Global Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Meningococcal Infections Vaccine Sales Volume (K doses) (2013-2018)
Table Global Meningococcal Infections Vaccine Sales (K doses) of Key Players/Suppliers (2013-2018)
Table Global Meningococcal Infections Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Meningococcal Infections Vaccine Sales Share by Players/Suppliers
Figure 2017 Meningococcal Infections Vaccine Sales Share by Players/Suppliers
Figure Global Meningococcal Infections Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Meningococcal Infections Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Meningococcal Infections Vaccine Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Meningococcal Infections Vaccine Revenue Share by Players
Table 2017 Global Meningococcal Infections Vaccine Revenue Share by Players
Table Global Meningococcal Infections Vaccine Sales (K doses) and Market Share by Type (2013-2018)
Table Global Meningococcal Infections Vaccine Sales Share (K doses) by Type (2013-2018)
Figure Sales Market Share of Meningococcal Infections Vaccine by Type (2013-2018)
Figure Global Meningococcal Infections Vaccine Sales Growth Rate by Type (2013-2018)
Table Global Meningococcal Infections Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Meningococcal Infections Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Meningococcal Infections Vaccine by Type (2013-2018)
Figure Global Meningococcal Infections Vaccine Revenue Growth Rate by Type (2013-2018)
Table Global Meningococcal Infections Vaccine Sales Volume (K doses) and Market Share by Region (2013-2018)
Table Global Meningococcal Infections Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Meningococcal Infections Vaccine by Region (2013-2018)
Figure Global Meningococcal Infections Vaccine Sales Growth Rate by Region in 2017
Table Global Meningococcal Infections Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Meningococcal Infections Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Meningococcal Infections Vaccine by Region (2013-2018)
Figure Global Meningococcal Infections Vaccine Revenue Growth Rate by Region in 2017
Table Global Meningococcal Infections Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Meningococcal Infections Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Meningococcal Infections Vaccine by Region (2013-2018)
Figure Global Meningococcal Infections Vaccine Revenue Market Share by Region in 2017
Table Global Meningococcal Infections Vaccine Sales Volume (K doses) and Market Share by Application (2013-2018)
Table Global Meningococcal Infections Vaccine Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Meningococcal Infections Vaccine by Application (2013-2018)
Figure Global Meningococcal Infections Vaccine Sales Market Share by Application (2013-2018)
Figure United States Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2018)
Figure United States Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Meningococcal Infections Vaccine Sales Price (USD/dose) Trend (2013-2018)
Table United States Meningococcal Infections Vaccine Sales Volume (K doses) by Players (2013-2018)
Table United States Meningococcal Infections Vaccine Sales Volume Market Share by Players (2013-2018)
Figure United States Meningococcal Infections Vaccine Sales Volume Market Share by Players in 2017
Table United States Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2013-2018)
Table United States Meningococcal Infections Vaccine Sales Volume Market Share by Type (2013-2018)
Figure United States Meningococcal Infections Vaccine Sales Volume Market Share by Type in 2017
Table United States Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2013-2018)
Table United States Meningococcal Infections Vaccine Sales Volume Market Share by Application (2013-2018)
Figure United States Meningococcal Infections Vaccine Sales Volume Market Share by Application in 2017
Figure Europe Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2018)
Figure Europe Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Meningococcal Infections Vaccine Sales Price (USD/dose) Trend (2013-2018)
Table Europe Meningococcal Infections Vaccine Sales Volume (K doses) by Players (2013-2018)
Table Europe Meningococcal Infections Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Europe Meningococcal Infections Vaccine Sales Volume Market Share by Players in 2017
Table Europe Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2013-2018)
Table Europe Meningococcal Infections Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Europe Meningococcal Infections Vaccine Sales Volume Market Share by Type in 2017
Table Europe Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2013-2018)
Table Europe Meningococcal Infections Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Europe Meningococcal Infections Vaccine Sales Volume Market Share by Application in 2017
Figure China Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2018)
Figure China Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Meningococcal Infections Vaccine Sales Price (USD/dose) Trend (2013-2018)
Table China Meningococcal Infections Vaccine Sales Volume (K doses) by Players (2013-2018)
Table China Meningococcal Infections Vaccine Sales Volume Market Share by Players (2013-2018)
Figure China Meningococcal Infections Vaccine Sales Volume Market Share by Players in 2017
Table China Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2013-2018)
Table China Meningococcal Infections Vaccine Sales Volume Market Share by Type (2013-2018)
Figure China Meningococcal Infections Vaccine Sales Volume Market Share by Type in 2017
Table China Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2013-2018)
Table China Meningococcal Infections Vaccine Sales Volume Market Share by Application (2013-2018)
Figure China Meningococcal Infections Vaccine Sales Volume Market Share by Application in 2017
Figure Japan Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2018)
Figure Japan Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Meningococcal Infections Vaccine Sales Price (USD/dose) Trend (2013-2018)
Table Japan Meningococcal Infections Vaccine Sales Volume (K doses) by Players (2013-2018)
Table Japan Meningococcal Infections Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Japan Meningococcal Infections Vaccine Sales Volume Market Share by Players in 2017
Table Japan Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2013-2018)
Table Japan Meningococcal Infections Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Japan Meningococcal Infections Vaccine Sales Volume Market Share by Type in 2017
Table Japan Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2013-2018)
Table Japan Meningococcal Infections Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Japan Meningococcal Infections Vaccine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2018)
Figure Southeast Asia Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Meningococcal Infections Vaccine Sales Price (USD/dose) Trend (2013-2018)
Table Southeast Asia Meningococcal Infections Vaccine Sales Volume (K doses) by Players (2013-2018)
Table Southeast Asia Meningococcal Infections Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Meningococcal Infections Vaccine Sales Volume Market Share by Players in 2017
Table Southeast Asia Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2013-2018)
Table Southeast Asia Meningococcal Infections Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Meningococcal Infections Vaccine Sales Volume Market Share by Type in 2017
Table Southeast Asia Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2013-2018)
Table Southeast Asia Meningococcal Infections Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Meningococcal Infections Vaccine Sales Volume Market Share by Application in 2017
Figure India Meningococcal Infections Vaccine Sales (K doses) and Growth Rate (2013-2018)
Figure India Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Meningococcal Infections Vaccine Sales Price (USD/dose) Trend (2013-2018)
Table India Meningococcal Infections Vaccine Sales Volume (K doses) by Players (2013-2018)
Table India Meningococcal Infections Vaccine Sales Volume Market Share by Players (2013-2018)
Figure India Meningococcal Infections Vaccine Sales Volume Market Share by Players in 2017
Table India Meningococcal Infections Vaccine Sales Volume (K doses) by Type (2013-2018)
Table India Meningococcal Infections Vaccine Sales Volume Market Share by Type (2013-2018)
Figure India Meningococcal Infections Vaccine Sales Volume Market Share by Type in 2017
Table India Meningococcal Infections Vaccine Sales Volume (K doses) by Application (2013-2018)
Table India Meningococcal Infections Vaccine Sales Volume Market Share by Application (2013-2018)
Figure India Meningococcal Infections Vaccine Sales Volume Market Share by Application in 2017
Table Sanofi-Pasteur Basic Information List
Table Sanofi-Pasteur Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Sanofi-Pasteur Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Beijing Tiantan Biological Products Basic Information List
Table Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Beijing Tiantan Biological Products Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Shanghai Institute of Biological Products Basic Information List
Table Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales Global Market Share (2013-2018
Figure Shanghai Institute of Biological Products Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Wuhan Institute of Biological Products Basic Information List
Table Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Wuhan Institute of Biological Products Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Lanzhou Institute of Biological Products Basic Information List
Table Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Hualan Biological Engineering Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Hualan Biological Engineering Meningococcal Infections Vaccine Sales Global Market Share (2013-2018
Figure Hualan Biological Engineering Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Chongqing Zhifei Biological Products Basic Information List
Table Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Zhejiang Tianyuan Bio-Pharmaceutical Basic Information List
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Global Market Share (2013-2018
Figure Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Walvax Biotechnology Basic Information List
Table Walvax Biotechnology Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Walvax Biotechnology Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Walvax Biotechnology Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Walvax Biotechnology Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Royal(Wuxi) Bio-Pharmaceutical Basic Information List
Table Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2013-2018)
Figure Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Growth Rate (2013-2018)
Figure Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales Global Market Share (2013-2018)
Figure Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningococcal Infections Vaccine
Figure Manufacturing Process Analysis of Meningococcal Infections Vaccine
Figure Meningococcal Infections Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningococcal Infections Vaccine Major Players in 2017
Table Major Buyers of Meningococcal Infections Vaccine
Table Distributors/Traders List
Figure Global Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure Global Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Meningococcal Infections Vaccine Price (USD/dose) and Trend Forecast (2018-2025)
Table Global Meningococcal Infections Vaccine Sales Volume (K doses) Forecast by Regions (2018-2025)
Figure Global Meningococcal Infections Vaccine Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Meningococcal Infections Vaccine Sales Volume Market Share Forecast by Regions in 2025
Table Global Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Meningococcal Infections Vaccine Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Meningococcal Infections Vaccine Revenue Market Share Forecast by Regions in 2025
Figure United States Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure United States Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure Europe Meningococcal Infections Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure China Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure China Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure Japan Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Meningococcal Infections Vaccine Sales Volume (K doses) and Growth Rate Forecast (2018-2025)
Figure India Meningococcal Infections Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Meningococcal Infections Vaccine Sales (K doses) Forecast by Type (2018-2025)
Figure Global Meningococcal Infections Vaccine Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Meningococcal Infections Vaccine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Meningococcal Infections Vaccine Revenue Market Share Forecast by Type (2018-2025)
Table Global Meningococcal Infections Vaccine Price (USD/dose) Forecast by Type (2018-2025)
Table Global Meningococcal Infections Vaccine Sales (K doses) Forecast by Application (2018-2025)
Figure Global Meningococcal Infections Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications